TY - JOUR
T1 - The regulatory function of T H 2 and ILC2 in asthma
AU - Huang, Yuying
AU - Cheng, Shipeng
AU - Zhang, Yaguang
AU - Sun, Bing
N1 - Publisher Copyright:
© 2018, Research Trends. All rights reserved.
PY - 2018
Y1 - 2018
N2 - Asthma is one of the most prevalent chronic diseases worldwide, affecting approximately 10% of adults and an even greater proportion of children. Type-2 innate lymphoid cell (ILC2)-and type 2 helper T cell (T H 2)-driven type 2 inflammation is a critical contributor to the pathogenesis of this disease. Various triggers, such as protease allergens, helminth parasites, fungi and influenza virus, can stimulate epithelial cells to release alarmins such as IL-33, IL-25 and thymic stromal lymphopoietin (TSLP) to drive ILC2s and T H 2 activation. In this review, we provide some latest advances in our understanding of the role of ILC2s and T H 2 in asthma. With regard to T H 2, we focus on transcriptional factors, ubiquitination, Notch signaling pathway and clinical research. In the case of ILC2s, we concentrate on transcriptional factors, co-stimulatory molecules, epigenetic and metabolic pathways in a cell-intrinsic way and on cell-cell interaction in a cell-extrinsic way. The questions in this field are also addressed.
AB - Asthma is one of the most prevalent chronic diseases worldwide, affecting approximately 10% of adults and an even greater proportion of children. Type-2 innate lymphoid cell (ILC2)-and type 2 helper T cell (T H 2)-driven type 2 inflammation is a critical contributor to the pathogenesis of this disease. Various triggers, such as protease allergens, helminth parasites, fungi and influenza virus, can stimulate epithelial cells to release alarmins such as IL-33, IL-25 and thymic stromal lymphopoietin (TSLP) to drive ILC2s and T H 2 activation. In this review, we provide some latest advances in our understanding of the role of ILC2s and T H 2 in asthma. With regard to T H 2, we focus on transcriptional factors, ubiquitination, Notch signaling pathway and clinical research. In the case of ILC2s, we concentrate on transcriptional factors, co-stimulatory molecules, epigenetic and metabolic pathways in a cell-intrinsic way and on cell-cell interaction in a cell-extrinsic way. The questions in this field are also addressed.
KW - Asthma
KW - ILC2
KW - T 2
KW - Therapeutic target
UR - https://www.scopus.com/pages/publications/85062176266
M3 - 文献综述
AN - SCOPUS:85062176266
SN - 0972-4567
VL - 19
SP - 115
EP - 128
JO - Current Trends in Immunology
JF - Current Trends in Immunology
ER -